MYGN · ISSUER CIK 899923
MYRIAD GENETICS INC
Between Aug 1, 2026 and Oct 29, 2026, 3 MYRIAD GENETICS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 22, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 202616:12 | Sep 21, 2026 | MYGN | Chief Financial Officer | F · Tax | $4.01 | −2,555 | 287,193 | -1% | $10K | ||
| Sep 17, 202616:34 | Sep 16, 2026 | MYGN | EVP, Commercial | A · Grant | — | +257,731 | 351,224 | +276% | — | ||
| Sep 8, 202616:18 | Sep 3, 2026 | MYGN | Chief Legal Officer | F · TaxLate 5d | $3.23 | −4,398 | 305,964 | -1% | $14K | ||
| Aug 17, 202616:26 | Aug 16, 2026 | MYGN | Chief Financial Officer | F · Tax | $3.03 | −8,761 | 289,748 | -3% | $27K |